Neuroprotective effects of granulocyte colony-stimulating factor against tramadol-induced cerebellar neurotoxicity
Tissue and Cell · vol. 94 · 102832-102832
المخرجات
Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.
3,288 output
Tissue and Cell · vol. 94 · 102832-102832
ClinicoEconomics and Outcomes Research · vol. Volume 17 · 217-232
Background and Objectives: Ofatumumab, a fully human anti-CD20 monoclonal antibody, is a promising disease-modifying therapy (DMT) for relapsing-remitting multiple sclerosis (RRMS). This study investigates its cost-effectiveness compared to teriflunomide from the perspective of Saudi healthcare payers. This comparison is crucial for informing treatment strategies and resource allocation in Saudi Arabia, where RRMS poses a significant healthcare burden and access to newer DMTs is evolving. Patients and Methods: A Markov model was constructed to evaluate the long-term cost-effectiveness of ofatumumab compared to teriflunomide for treating RRMS in Saudi Arabia. This model simulates disease progression over 10 years, a timeframe chosen for its clinical relevance and consistency with similar studies. To reflect the Saudi patient population, the model uses a hypothetical cohort with characteristics mirroring those in the ASCLEPIOS I/II clinical trials. The model incorporates transition probabilities between disease states, primarily derived from the British Columbia MS (BCMS) database and further refined using data from the ASCLEPIOS trials. To ensure relevance to the Saudi context, local data sources were utilized, including drug costs from the Saudi Food and Drug Authority (SFDA) and health state costs from published local studies. Clinical expert input was incorporated to validate model assumptions.The primary outcome measure was the incremental cost per quality-adjusted life-year (QALY) gained. Sensitivity analyses were conducted to assess the robustness of the model findings. Results: Compared to teriflunomide, ofatumumab yielded incremental cost-effectiveness ratios (ICERs) of $46,188 per QALY over the 10-year period. Ofatumumab demonstrated a greater impact on reducing disability progression, particularly in the early stages of the disease. At a willingness-to-pay (WTP) threshold of $99,120 per QALY, ofatumumab demonstrated a 99.14% probability of cost-effectiveness in probabilistic sensitivity analyses. Conclusion: This cost-effectiveness analysis demonstrates that ofatumumab is a cost-effective treatment for RRMS in Saudi Arabia, with an ICER below the WTP. Policymakers should consider including ofatumumab in national formularies and prioritize its use in early-stage RRMS to maximize patient benefit and cost-effectiveness.
Aesthetic Plastic Surgery · vol. 49 (16) · 4621-4637
Frontiers in Public Health · vol. 13 · 1542339-1542339
Objectives This study aimed to assess the prevalence of non-communicable diseases (NCDs) among Saudi adolescents, focusing on obesity, conduct disorder, asthma, and anxiety, and to identify potential risk factors associated with these conditions. Methods A retrospective cross-sectional analysis was conducted using data from 2,160 adolescents sourced from official government databases and peer-reviewed literature. Statistical methods included one-way ANOVA, chi-square tests, logistic regression, and Pearson’s correlation coefficient, with significance set at p < 0.05 and a 95% confidence interval. Results The prevalence of NCDs among Saudi adolescents was 11.8%. Obesity was the most common condition (odds ratio [OR] = 1.24, p = 0.006), followed by conduct disorder (OR = 1.12, p = 0.041), asthma (OR = 1.09, p = 0.036), and anxiety (OR = 1.06, p = 0.042). Pearson’s correlation revealed significant associations between these disorders and adolescence stages. Conclusion Obesity, conduct disorder, asthma, and anxiety are significant health challenges for Saudi adolescents. These findings highlight the role of lifestyle factors such as diet and physical inactivity. Targeted interventions are needed to promote healthy behaviors and mitigate the long-term risks of these conditions.
BMC Microbiology · vol. 25 (1) · 63-63
BACKGROUND: Acinetobacter baumannii is an opportunistic bacteria associated primarily with hospital-acquired infections. Its tendency to acquire or donate resistance genes to neighboring bacteria is a major concern. Tetracyclines have shown promise in treating A. baumannii infections, but tetracycline resistance is growing globally in A. baumannii isolates. OBJECTIVES: The study aimed to study (1) the prevalence of multidrug-resistant (MDR) A. baumannii infections at Suez Canal University Hospitals, (2) the distribution of efflux pump genes AdeA &B, TetA, and TetB, and (3) the effect of efflux pump inhibitor (CCCP) on tetracycline-resistant isolates. METHODS: Clinical samples (457) were collected (blood, urine, sputum, ETA, pus, and pleural fluid), followed by A. baumannii isolation and identification, PCR detection of efflux pump genes, and detection of tetracycline susceptibility and its MIC before and after treatment with the efflux pump inhibitor (CCCP). RESULTS: A total of 31 A. baumannii isolates were recovered (6.78%). The highest rate of isolation was from the ICU (48.3%) from the ET aspirate samples (48.3%). The efflux system AdeA and TetB genes were distributed in 100% of isolates, whereas AdeB was found in 93.5% of isolates and the TetA gene in 87.1% of isolates. All A. baumannii isolates were MDR showing resistance to three or more classes of antibiotics. 45% of the isolates showed a 4-fold reduction of MIC and 12.9% showed a 2-fold reduction in the MIC. CONCLUSIONS: Efflux pump is an important mechanism for tetracycline resistance among A. baumannii isolates.
Journal of Neuroscience Methods · vol. 416 · 110386-110386
PLoS ONE · vol. 20 (1) · e0316146-e0316146
This study presents T-1-NBAB, a new compound derived from the natural xanthine alkaloid theobromine, aimed at inhibiting VEGFR-2, a crucial protein in angiogenesis. T-1-NBAB's potential to interacts with and inhibit the VEGFR-2 was indicated using in silico techniques like molecular docking, MD simulations, MM-GBSA, PLIP, essential dynamics, and bi-dimensional projection experiments. DFT experiments was utilized also to study the structural and electrostatic properties of T-1-NBAB. Computational analysis was performed to predict the ADME-Tox profiles of T-1-NBAB. After semisynthesis, the in vitro results showed that T-1-NBAB effectively inhibits VEGFR-2, with an IC50 of 0.115 μM, compared to sorafenib's 0.0591 μM. In vitro tests also demonstrated significant activity of T-1-NBAB against breast cancer cell lines MCF7 and T47D, with IC50 values of 16.88 μM and 61.17 μM, respectively, and high selectivity. Importantly, T-1-NBAB induced early and late apoptosis in MCF7 cells, indicating its potential as a strong anticancer agent. Additionally, T-1-NBAB reduced the migration and healing abilities of MCF7 cells, suggesting it could be a promising anti-angiogenic agent. Overall, these findings suggest that T-1-NBAB is a promising lead compound for further research as a potential treatment for breast cancer.
Journal of Industrial Textiles · vol. 55
Jute, an important natural fiber crop grown in Southeast Asia, particularly in India, Bangladesh, and Thailand, has received considerable attention because to its superior mechanical characteristics, high cellulose content, affordability, biodegradability, and benefits for the environment. The data obtained from Web of Science (WoS) and Scopus databases from 2004 to 2023, it explores publication trends, active authors, sources, institutions, and countries contributing to the scientific literature. The investigation uses bibliometric tools like Bibliometrix and VOS viewer to map the intellectual structure and research links. The findings show a steady increase in scholarly production, with a noteworthy high in 2022, highlighting growing awareness of jute’s potential as a sustainable substitute for synthetic materials. The finding shows the critical role that Indian contributors and organizations play in developing sustainability study results, as well as worldwide collaborations, especially with nations in South and Southeast Asia. This research illustrates the important of combining traditional knowledge with emerging technology like precision farming and artificial intelligence (AI) to deal with sustainability challenges. It also highlights weakness such a lack of interdisciplinary collaboration and financial support. These findings help to shape sustainable methods in jute agriculture, with implications for protecting the environment and social development.
Current Microbiology · vol. 82 (2) · 68-68
Journal of Multidisciplinary Healthcare · vol. Volume 18 · 1-12
Background: Background: Strain-Counterstrain (SCS) therapy is a manual therapeutic technique used to treat myofascial pain by addressing tender points through passive positioning. Despite anecdotal evidence, limited peer-reviewed research supports its efficacy in chronic low back pain (LBP). This study evaluates the effects of SCS combined with exercise on pain severity, lumbar range of motion (ROM), and functional disability in patients with chronic LBP. Methods: A randomized controlled trial was conducted with 30 participants aged 45-55 years, divided into Group A (SCS + Exercise) and Group B (Exercise Only). Outcome measures included pain intensity, lumbar ROM (flexion, extension, side bending), and functional disability (Oswestry Disability Index). Assessments were conducted at baseline and after four weeks of intervention. MANOVA was performed to evaluate group, time, and interaction effects, with detailed univariate follow-ups and effect sizes. Reliability of ROM measurements was ensured using intraclass correlation coefficients (ICC > 0.90). Results: MANOVA revealed statistically significant group, time, and interaction effects for all outcomes (Wilks' Lambda = 0.065, F (6, 51) = 91.34, p < 0.001). Pain severity decreased by 26.7% in Group A compared to 5.2% in Group B (F (1, 56) = 65.78, p < 0.001, partial η² = 0.77). Lumbar ROM improved significantly in Group A for flexion (10.9%), extension (20.3%), and right-side bending (17.7%) (p < 0.001, partial η² = 0.68-0.74), with no significant improvement in left-side bending. Functional disability scores reduced by 25.2% in Group A versus 2.3% in Group B (F (1, 56) = 53.45, p < 0.001, partial η² = 0.73). Conclusion: SCS therapy combined with exercise significantly reduces pain, improves lumbar ROM, and enhances functional capacity in patients with chronic LBP compared to exercise alone. These findings highlight SCS as a promising adjunctive treatment for managing chronic musculoskeletal pain. Future studies should investigate long-term outcomes and further refine treatment protocols.
Computer Modeling in Engineering & Sciences · vol. 142 (3) · 2487-2511
Fundoscopic diagnosis involves assessing the proper functioning of the eye’s nerves, blood vessels, retinal health, and the impact of diabetes on the optic nerves. Fundus disorders are a major global health concern, affecti... | Find, read and cite all the research you need on Tech Science Press
Journal of Food Biochemistry · vol. 2025 (1)
Ethnopharmacological Relevance: Bisphenol A (BPA) is a widely used chemical, particularly in producing epoxy resins and polycarbonate plastics, which can contaminate food and water sources. Even low levels of BPA exposure have been associated with negative impacts on neural development, leading to neurotoxicity. Purple carrots, known for their health‐promoting properties, are rich in bioactive compounds such as polyphenols. Materials and Methods: This study aimed to evaluate the neuroprotective effects of purple carrot extract in mitigating BPA‐induced neurotoxicity in albino rats. Forty albino rats were divided into four groups: Group I (control) received water and a standard diet. Group II (BPA group) was orally administered 50 mg/kg body weight of BPA dissolved in 1 mL of olive oil daily for 30 days. Group III received 400 mg/kg of purple carrot extract along with 50 mg/kg of BPA daily. Group IV received 800 mg/kg of purple carrot extract along with 50 mg/kg of BPA daily, following the same 30‐day oral administration protocol. Results: The results showed that treatment with purple carrot extract increased serum levels of critical neurotransmitters, including serotonin, dopamine, acetylcholine, acetylcholineesterase, and gamma‐aminobutyric acid (GABA). Additionally, brain tissue analysis revealed elevated activity of antioxidant enzymes, such as catalase (CAT) and superoxide dismutase (SOD), in response to extract administration. Conversely, the extract significantly reduced levels of malondialdehyde (MDA), α‐tumor necrosis factor (α‐TNF), and interleukin‐6 (IL‐6) in brain tissues compared to the BPA‐only group. These results indicate that purple carrot extract regulates genes related to oxidative stress, inflammation, and apoptosis in a dose‐dependent manner during BPA‐induced neurotoxicity. At a dose of 400 mg/kg, the extract increased the expression of antioxidant genes like Nrf2 and HO‐1 while reducing the pro‐apoptotic marker Bax. At the higher dose of 800 mg/kg, these protective effects were even more pronounced, leading to enhanced neuroprotection through increased antioxidant and antiapoptotic gene expression and reduced inflammation, mainly through the MAPK pathway. Conclusion: The study demonstrates that purple carrot extract reduces BPA‐induced neurotoxicity in rats by enhancing antioxidants, neurotransmitters, and anti‐inflammatory responses, suggesting natural protection against BPA‐related neural damage.
Computer Modeling in Engineering & Sciences · vol. 143 (2) · 2155-2183
With the increasing complexity of hotel selection, traditional decision-making models often struggle to account for uncertainty and interrelated criteria. Multi-criteria decision-making (MCDM) techniques, particularly those b... | Find, read and cite all the research you need on Tech Science Press
European Journal of Clinical Investigation · vol. 56 (1) · e70158-e70158
BACKGROUND: Elderly frailty is a multifaceted clinical condition with diminished physiological reserves and increased stress susceptibility. It increases disability, hospitalization and mortality rates, requiring multidomain therapy. Structured physical-activity-based medical treatment can reduce frailty in physical, mental and emotional areas. This assessment distinguishes outcomes among validated frailty models (phenotype-based vs. deficit-accumulation) to highlight model-specific effects. OBJECTIVES: The present systematic review assesses the efficacy of structured physical-activity-based physiotherapy in reducing frailty and enhancing physical, cognitive and emotional outcomes in persons aged ≥60. It highlights a critical data gap neglected by past studies by distinguishing intervention effects across proven frailty models (phenotype-based and deficit-accumulation frameworks). METHODOLOGY: The review used PRISMA criteria and the PICOS framework to find relevant papers published between January 2002 and December 2025. PubMed, Scopus, Cochrane Library and Embase were searched. RCTs and longitudinal cohort studies on physiotherapy or structured physical-activity therapies (e.g. resistance training, aerobic conditioning, balance exercises, multimodal programs) for individuals aged ≥60 years were eligible. Frailty, physical performance and quality of life were evaluated. Cochrane Risk of Bias 2.0 was used for randomised studies and ROBINS-I for non-randomised designs. RESULTS: 36 trials covered varied physiotherapy and structured physical-activity regimens. Participants, mostly aged ≥60, were mostly women (approximately two-thirds of the sample). The majority of investigations found that resistance training increased muscle strength and decreased frailty by 20%-35%. Exercises involving balance reduced fall risk by 25%-35%, while aerobic workouts improved gait and cardiovascular fitness. Multimodal interventions reversed frailty in 41%-50% of individuals and improved cognitive and emotional outcomes the highest. Physical performance, quality of life and functional independence improved across frailty models in weighted summaries. CONCLUSION: Structured physical-activity-based physiotherapy therapies, especially multimodal programs, reduce frailty and enhance physical, cognitive and emotional resilience in older persons, highlighting their value in comprehensive geriatric care.
BMC Surgery · vol. 26 (1) · 69-69
AIM: This study aimed to conduct an updated systematic review and meta-analysis of comparative studies evaluating the efficacy and safety of tranexamic acid (TXA) during bariatric surgery. METHODS: Six databases were searched up to September 2, 2025. The primary endpoint was the rate of postoperative bleeding. Secondary endpoints included transfusion, hematoma, reoperation, thromboembolic events, operative time, and hospital stay. Outcomes were pooled as risk ratios (RR) or mean differences (MD) with 95% confidence intervals (CI) using a random-effects model. RESULTS: Ten studies (11 treatment arms; 2,137 patients, mostly undergoing laparoscopic sleeve gastrectomy) were included. TXA, usually given as a single intravenous dose at induction, was associated with a lower risk of postoperative bleeding (9 studies; RR 0.57, 95% CI 0.36–0.88), although this effect was not robust in leave-one-out sensitivity analyses. No significant differences were observed for blood transfusion, hematoma, or reoperation. TXA modestly reduced operative time and length of stay, but these differences were not clinically important. No thromboembolic events were reported in TXA-treated patients, and overall risk of bias was judged as low to moderate across most studies. CONCLUSION: TXA may reduce postoperative bleeding, but the effect was not robust in sensitivity analyses; though further high-quality RCTs are needed.